Premium Information is available for this item - Upgrade for $1 a day

6505-01-278-1124

Etoposide Capsules

6505012781124 012781124 VEPESID CAPSULES VEPESID 3091-45 NDC00015-3091-45 VEPESID 50 MG CAPSULAS 19-001-3117

INC: 47750 Etoposide Capsules

Managed by United States

NSN Created on 30 Apr 1988

Data Last Changed
May 2023

NATO Update Count
13

NATO Data Quality

6505-01-278-1124 ETOPOSIDE CAPSULES 6505012781124 012781124 1/1 — NSN 6505-01-278-1124 (Generic Image) 1/1

Marketplace 6505-01-278-1124

Need Help?
Request a Quotation from participating marketplace vendors

Updated Every Day

6505-01-278-1124 RQST NE

Updated Every Day

6505-01-278-1124 RQST

Updated Every Day

6505-01-278-1124 RQST NE

Related Documents 6505-01-278-1124 5+ Documents (More...)

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-278-1124 Etoposide Capsules 6505012781124 012781124

VEPESID CAPSULES VEPESID 3091-45 NDC00015-3091-45 VEPESID 50 MG CAPSULAS 19-001-3117 Managed by United
29398 - Mead Johnson & Company, Llc (Active) Primary Buy RNCC 3 RNVC 2 DAC 4 VEPESID CAPSULES
6505-19-001-3117 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-278-1124 Etoposide Capsules 6505012781124

https//www.nsnlookup.com
/fsg-65/fsc-6505/br

6505-19-001-3117 Etoposide Capsules 6505190013117 190013117

6505-01-278-1124 6505-27-004-0143 https//www.nsnlookup.com /fsg-65/fsc-6505/br 6505-19-001-3117
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-278-1124 Etoposide Capsules 6505012781124
012781124 Etoposide Capsules 65051900131171900131176505-19-001-3117 5+ Documents ( More... ) https//www.nsnlookup.com

https//www.nsnlookup.com
/fsg-65/fsc-6505/br

6505-19-001-1820 Etoposide Capsules 6505190011820 190011820

enable JavaScript in your web browser . 6505-19-001-1820Etoposide Capsules6505190011820 190011820 VEPESID
Etoposide Capsules 6505190013117 190013117 6505998986303998986303 /fsg-65/fsc-6505/br 6505-19-001-3117
6505-01-278-1124 6505-27-004-0143 6505-99-898-6394 6505-19-001-1820 https//www.nsnlookup.com /fsg

https//www.nsnlookup.com
/fsg-65/fsc-6505/uk

6505-99-898-6303 Etoposide Capsules 6505998986303 998986303

enable JavaScript in your web browser . 6505-99-898-6303Etoposide Capsules6505998986303 998986303 VEPESID
6505-01-278-1124 6505-27-004-0143 NATO Stock https//www.nsnlookup.com /fsg-65/fsc-6505/br 6505-
19-001-3117 Etoposide Capsules 6505190013117 190013117 /fsc-6505/tr 6505-27-004-0143 Etoposide Capsules

https//www.nsnlookup.com
/fsg-65/fsc-6505/uk

6505-99-898-6394 Etoposide Capsules 6505998986394 998986394

enable JavaScript in your web browser . 6505-99-898-6394Etoposide Capsules6505998986394 998986394 VEPESID
enable JavaScript in your web browser . 6505-19-001-1820Etoposide Capsules6505190011820 190011820 VEPESID
enable JavaScript in your web browser . 6505-99-898-6303Etoposide Capsules6505998986303 998986303 VEPESID

Restrictions 6505-01-278-1124

6505-01-278-1124 is a Etoposide Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). This item does not contain a precious metal.

Import and Export 6505-01-278-1124

Schedule B: Subscribe to View Schedule B
HTS Code: Subscribe to View HTS Code

End Users 6505-01-278-1124

MOE Rule:: V542
Effective Date:: 1 Apr 1991; AMC 0 AMSC 0

Brazil (YA01)
Effective Date:: 1 Sep 2011

Approved Sources 6505-01-278-1124

Part Number
Manufacturer
Status
3091-45: 29398 - Mead Johnson & Company, Llc (Active); Primary Buy; RNCC 3 RNVC 2 DAC 4
NDC00015-3091-45: 29398 - Mead Johnson & Company, Llc (Active); Primary Buy; RNCC 3 RNVC 2 DAC 4
VEPESID CAPSULES: 29398 - Mead Johnson & Company, Llc (Active); Incomplete Secondary Reference; RNCC 5 RNVC 1 DAC 4
VEPESID: 29398 - Mead Johnson & Company, Llc (Active); Incomplete Secondary Reference; RNCC 5 RNVC 1 DAC 4
VEPESID 50 MG CAPSULAS: 006XK - Bristol-Myers Squibb Farmaceutica (Active); Secondary Buy; RNCC 5 RNVC 2 DAC 6
19-001-3117: INTE9 - Nato Stock Number Potential (Active); NATO Reference; RNCC 6 RNVC 9 DAC 9

Datasheet 6505-01-278-1124

Characteristic
Specifications
FIIG: A510U0
Active Medicament Medicinal Strength [AKJA]: 50.000 Milligrams Etoposide Active Ingredient
Capsule Content Form [CQLS]: Any Acceptable
Capsule Type [AKJC]: Any Acceptable
Capsule Primary Container Content Quantity [CYLZ]: 20.000
Features Provided [CBBL]: Individually Sealed
Part Name Assigned By Controlling Agency [CXCY]: Etoposide Capsules 50Mg I.S. 20S Pg
Primary Container Type [CQCT]: Strip
Protective Storage Feature [AJCN]: Antineoplastic Drug And Requires Refrigeration Storage Between 2 To 8 Deg Celsius And Subject To Damage By Freezing

Management Data 6505-01-278-1124

Subscribe
View Prices

Effective Date: Organization; Unit of Issue; Unit Price; Qty Unit Pack
Sep 1992: Veterans Administration (VA); PG; Subscribe

MOE: USC; Code; Statement; Order of Use; Jump To Code; Qty Per Assy; UOM; Technical Document; Quantative Expression
Veterans Administration (VA): V; K; U/I Contains 20 Ea; 00000000020EA

Similar Supply Items to 6505-01-278-1124

Freight Information 6505-01-278-1124

6505-01-278-1124 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-278-1124 has a variance between NMFC and UFC when transported by rail and the description should be consulted.